PNT
Panther Metals Ltd
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-30.97%
Annual Growth
3 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Panther Metals Ltd. focuses on identifying and acquiring prospective mineral exploration projects. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-12-10. The firm is focused on the exploration and development of battery and precious metals. The firm has drill ready gold and nickel targets across five projects Laverton Western Australia and a further two gold projects in the Northern Territory. Its projects include battery metals projects and precious metals project. Its battery metals project includes Coglia project and Red Flag project. Its Precious Metals project include Burtville East prospect, Ironstone prospect, Annaburroo project, Marrakai project, 40-Mile Camp Prospect, Comet Well Prospect, and Mikado project. Coglia Nickel-Cobalt Project located around 70 kilometers (km) southeast of Laverton. The Red Flag is located in a prolific nickel-cobalt belt, 25 km west of Laverton. Burtville East is located within a 50 km radius of four gold mills. The Ironstone Project is located 50 km southeast of Laverton.
📈 Performance
Price History
-94.18%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in PNT
1
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
9 weeks
💵 Average investment amount
$5,294
⏰ Last time a customer invested in PNT
63 days
PNT investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
100%
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
100%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in PNT also invest in...
PMGOLD
PMGOLD.AX was created on 2003-05-09 by Perth Mint. The fund's investment portfolio concentrates primarily on gold commodities. PMGOLD.AX is designed to track the international price of gold in Australian dollars and offers investors a simple, low cost way to access the returns on gold.
🙌 Performance (5Yr p.a)
18.66%
📊 Share price
$41.70 AUD
📈 HIGH PRICE GROWTH
ETPMAG
ETPMAG.AX was created on 2009-01-02 by Global X. The fund's investment portfolio concentrates primarily on silver commodities. ETFS Physical Silver (ETPMAG.AX) is designed to offer investors a simple, costefficient and secure way to access physical silver by providing a return equivalent to the movements in the silver spot price less the applicable management fee.
🙌 Performance (5Yr p.a)
16.34%
📊 Share price
$43.81 AUD
📈 HIGH PRICE GROWTH
IMU
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. The company is headquartered in Sydney, New South Wales. The company is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.
🙌 Performance (5Yr p.a)
5.52%
📊 Share price
$0.04 AUD
🧬 BIOTECHNOLOGY
Novatti Group Ltd. provides software technology and systems integration services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2016-01-18. The Company’s solutions include issuing, acquiring, processing, and billing. Its segments include Payments AU and NZ, Payments International, and Technology Solutions. Payments AU/NZ segment include Payments Acquiring, Card Issuing, Cross Border Payments and Novatti Billpay. Payments International segment include ATX Payments (Malaysia) and Flexepin Payments (Europe). Technology Solutions include enterprise, automation and billing software. The company provides cash voucher services to a global customer base to enable cash to be transferred to a digital form for use on e-commerce trading and services Websites, with operations in Australia and Canada and pin-point solutions for other countries and regions. The company also offers Cross-border Payments provides wholesale payment facilitation in and out of Australia for its own affiliated agents.
🙌 Performance (5Yr p.a)
-17.23%
📊 Share price
$0.03 AUD
🤖 TECHNOLOGY
GDX.AX was created on 2015-06-26 by VanEck. The fund's investment portfolio concentrates primarily on materials equity. To achieve this investment objective, GDX.AX employs a passive management strategy of investing in the NYSE-listed GDX.AX issued and operated by VanEck in the United States.
🙌 Performance (5Yr p.a)
7.39%
📊 Share price
$55.57 AUD
🧱 MATERIALS
🕊️ SOCIALLY AWARE
📈 HIGH PRICE GROWTH
Want more shares? Try these...
Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb. The company is headquartered in Melbourne, Victoria and currently employs 254 full-time employees. Its solutions include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a synthetic, biodegradable and biocompatible device designed to facilitate the dermis to grow within a patented polyurethane matrix when lost through extensive surgery, trauma or burn. NovoSorb BTM is indicated for use in the management of wounds, including partial and full thickness wounds, pressure ulcers, venous and diabetic ulcers, chronic and vascular ulcers, surgical wounds, trauma wounds and draining wounds. Its development program covers breast sling, hernia, and orthopedic applications. NovoSorb MTX is available in a range of sizes to address acute and chronic dermal wounds and is comprised of a 2mm biodegradable foam with no sealing membrane.
🙌 Performance (5Yr p.a)
1.24%
📊 Share price
$2.06 AUD
🩺 HEALTH CARE
Pantoro Ltd. engages in the exploration and processing of gold mining. The company is headquartered in Perth, Western Australia. The Halls Creek Project owns the only commercial scale gold processing facility in the Kimberley Region of Western Australia, with the closest plant approximately 300 kilometers (km) to the south. Its Norseman Gold Project is located in the Eastern Goldfields of Western Australia, at the southern end of the Norseman-Wiluna greenstone belt. The project lies approximately 725 km east of Perth, 200 km south of Kalgoorlie, and 200 km north of Esperance. The project comprises various near-contiguous mining tenements, and its tenure includes approximately 70 lineal km of the prospective Norseman-Wiluna greenstone belt covering approximately 800 square kilometers. The firm has a portfolio of regional exploration targets located near the Nicolsons Project, approximately 45 km southwest of Halls Creek in Western Australia.
🙌 Performance (5Yr p.a)
-8.00%
📊 Share price
$0.09 AUD
⛏️ MINING